Citi wins pharma cash mandate

Hospira awards Citi a seven-market cash mandate.

Pharmaceutical company Hospira has awarded Citi's global transaction services team its primary cash and liquidity management mandate in seven Asia-Pacific markets.

Under the mandate, global pharmaceutical and medical delivery company Hospira will use Citi's single window, known as CitiDirect, as well as other cash solutions in Australia, Hong Kong, Malaysia, New Zealand, the Philippines, Singapore and Taiwan.

We are currently working on several cash management initiatives in Asia-Pacific and we are extremely pleased to partner...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition